| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |